Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

Grainger John D.; Locatelli Franco; Chotsampancharoen Thirachit; Donyush Elena; Pongtanakul Bunchoo; Komvilaisak Patcharee; Sosothikul Darintr; Drelichman Guillermo; Sirachainan Nongnuch; Holzhauer Susanne; Lebedev Vladimir; Lemons Richard; Pospisilova Dagmar; Ramenghi Ugo; Bussel James B.; Bakshi Kalpana K.; Iyengar Malini; Chan Geoffrey W.; Chagin Karen D.; Theodore Dickens; Marcello Lisa M.; Bailey Christine K.

首页> 外文期刊>The Lancet >Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

【24h】

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

机译：Eltrombopag用于儿童慢性免疫性血小板减少症（PETIT2）：一项随机，多中心，安慰剂对照的试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The thrombopoietin receptor agonist eltrombopag has been shown to be safe, tolerable, and effective for adults with chronic immune thrombocytopenia. We aimed to investigate the safety and efficacy of eltrombopag for children with chronic immune thrombocytopenia.

机译：背景技术血小板生成素受体激动剂Eltrombopag已被证明对于患有慢性免疫性血小板减少症的成人是安全，可耐受和有效的。我们旨在研究Eltrombopag对患有慢性免疫性血小板减少症的儿童的安全性和有效性。

著录项

来源
《The Lancet》 |2015年第10004期|共10页
作者
Grainger John D.; Locatelli Franco; Chotsampancharoen Thirachit; Donyush Elena; Pongtanakul Bunchoo; Komvilaisak Patcharee; Sosothikul Darintr; Drelichman Guillermo; Sirachainan Nongnuch; Holzhauer Susanne; Lebedev Vladimir; Lemons Richard; Pospisilova Dagmar; Ramenghi Ugo; Bussel James B.; Bakshi Kalpana K.; Iyengar Malini; Chan Geoffrey W.; Chagin Karen D.; Theodore Dickens; Marcello Lisa M.; Bailey Christine K.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial [J] . Grainger John D., Locatelli Franco, Chotsampancharoen Thirachit, The Lancet . 2015,第10004期

机译：Eltrombopag用于儿童慢性免疫性血小板减少症（PETIT2）：一项随机，多中心，安慰剂对照的试验
2. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial [J] . Ghanima Waleed, Khelif Abderrahim, Waage Anders, The Lancet . 2015,第9978期

机译：Rituximab作为成人免疫血小板减少症的二线治疗（Ritp试验）：多期，随机，双盲，安慰剂对照试验
3. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial [J] . Ghanima Waleed, Khelif Abderrahim, Waage Anders, The Lancet . 2015,第9978期

机译：利妥昔单抗作为成人免疫性血小板减少症的二线治疗（RITP试验）：一项多中心，随机，双盲，安慰剂对照试验
4. Cluster Randomised Controlled Trial of a Mobile Monitoring and Feedback Tool Embedded in a Counselling Protocol to Stimulate Physical Activity in Chronically Ill Patients Study protocol of the It's LiFe! RCT [C] . Sanne van der Weegen, Huibert Tange, Trudy van der Weijden, International Conference on eHealth, Telemedicine, and Social Medicine . 2015

机译：集群随机对照试验的移动监测和反馈工具嵌入辅导议定书中，以刺激其生命的慢性病患者的体育活动！ RCT.
5. Effect of whey protein quality on physiological response to chronic resistance exercise in trained men: A double-blind, placebo-controlled, randomized trial. [D] . Lockwood, Christopher M. 2010

机译：乳清蛋白质量对训练有素的男性对慢性抵抗运动的生理反应的影响：一项双盲，安慰剂对照，随机试验。
6. Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial [O] . Julie Pell, Rosemary Greenwood, Jenny Ingram, 2018

机译：试验方案：一项针对新诊断的免疫性血小板减少症的一线治疗途径的多中心随机试验：标准类固醇治疗与类固醇和霉酚酸酯联合治疗。飞行试验
7. Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis [O] . Jiaxing Zhang, Yi Liang, Yuan Ai, 2018

机译：Eltompagag与romiplostim治疗患有持久性或慢性免疫血小板减少症的儿童：一种系统综述，其掺入间接 - 比较荟萃分析

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅